YUSIMRY™ (adalimumab-aqvh) product image
Coherus Launches YUSIMRY™, a Biosimilar of Humira®, at $995 per Carton in U.S.
July 03, 2023 08:30 ET | Coherus BioSciences, Inc.
–$995 per carton (two 40 mg/0.8 mL autoinjectors) represents a discount of more than 85% compared to Humira® – – YUSIMRY™ meets high unmet need by providing patients, employers, physicians and...